Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

Target Cell Response to Hormones

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?

Frontiers in pharmacology·2024

Same author

Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.

Journal of immunology (Baltimore, Md. : 1950)·2023

Same author

Themed issue: 'New avenues in cancer prevention and treatment'.

British journal of pharmacology·2022

Same author

Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters.

European journal of pharmacology·2021

Same author

Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021

Same author

HLA Class-II‒Restricted CD8<sup>+</sup> T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients.

The Journal of investigative dermatology·2021

Search research articles

Related Experiment Videos

Interactions between TNF and GnRH.

David J MacEwan¹

¹School of Chemical Sciences and Pharmacy, University of East Anglia, Norwich, NR4 7TJ, UK. d.macewan@uea.ac.uk

Neurochemical Research

|November 7, 2007

Summary

This summary is machine-generated.

Tumour necrosis factor (TNF) plays a key role in inflammatory diseases and reproductive functions. Understanding TNF receptor (TNFR) and gonadotropin-releasing hormone (GnRH) signaling is crucial for developing new therapies.

Related Experiment Videos

Area of Science:

Immunology and Endocrinology
Cellular Signaling Pathways

Background:

Tumour necrosis factor (TNF) and its receptors (TNFRs) are involved in numerous physiological processes.
TNF is implicated in the pathology of various diseases, including inflammatory conditions and potentially reproductive disorders.
Anti-TNF therapies like etanercept and infliximab have shown efficacy in treating inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

Purpose of the Study:

To discuss the cellular signaling mechanisms of TNFRs.
To explore the signaling pathways of the gonadotropin-releasing hormone (GnRH) receptor.
To examine the interactions between TNF, GnRH, and gonadotrophs, particularly concerning reproductive functions and conditions like endometriosis.

Main Methods:

Review of existing literature on TNF, TNFR, and GnRH signaling.
Discussion of cellular signaling machinery.
Analysis of the physiological roles and interactions of these pathways.

Main Results:

TNFRs utilize complex signaling machinery for diverse cellular responses.
GnRH receptor signaling mechanisms are distinct but interact with broader physiological axes.
TNF exerts anti-gonadotrophic effects and influences reproductive processes, including endometriosis development.

Conclusions:

TNF signaling is interconnected with the hypothalamic-pituitary-gonadal axis.
Understanding these interactions is vital for comprehending TNF's role in reproductive health and disease.
Further research into TNF-GnRH interactions may reveal novel therapeutic targets for inflammatory and reproductive conditions.